NSEAnalysts/Institutional Investor Meet/Con. Call Updates12 Oct 2026 · 12 Oct 2026, 11:45 am
Analysts/Institutional Investor Meet/Con. Call Updates
Mankind Pharma Limited · MANKIND
✦ AI SummaryResults
Mankind Pharma Limited has informed the Exchange about the schedule of an earnings conference call to discuss the business and financial results of the Company for Q2 & H1 FY27 on October 26, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
MANKIND1_12102026114545_Intimation_of_Earning_Call.pdf
View document text
October 12, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Sub.: Intimation of Earnings Conference Call for Q2 & H1 FY27
Ref.: Regulation 30 & 51 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015
With reference to the captioned subject, we wish to inform you that the management of the
Company will host an earnings conference call on Monday, October 26, 2026, at 06:00 P.M.
(IST), to discuss the business and financial results of the Company for Q2 & H1 FY27.
Please find the link for the earnings conference call: Q2 & H1 FY27 Earnings Conference Call
Above information is also available on the website of the Company at
www.mankindpharma.com.
Kindly take the same on record.
Thanking you
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer